BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 9758366)

  • 1. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
    Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis-antagonizing protein Bcl-2 expression, distribution in non-Hodgkin's lymphoma and its clinical significance].
    Chen X; Huang G; Wang W
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):140-2. PubMed ID: 10743081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies.
    Said JW; Sassoon AF; Shintaku IP; Corcoran P; Nichols SW
    Mod Pathol; 1990 Nov; 3(6):659-63. PubMed ID: 2263590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
    Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
    Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
    Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
    Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of Ki-67 and bcl-2 expression in lymphoid malignancies.
    Wang PL; Peh SC
    Malays J Pathol; 1997 Jun; 19(1):59-64. PubMed ID: 10879243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
    Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
    Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors.
    Raphael M; Gentilhomme O; Tulliez M; Byron PA; Diebold J
    Arch Pathol Lab Med; 1991 Jan; 115(1):15-20. PubMed ID: 1987908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
    Kondo E; Yoshino T; Yamadori I; Matsuo Y; Kawasaki N; Minowada J; Akagi T
    Am J Pathol; 1994 Aug; 145(2):330-7. PubMed ID: 7519826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous B cell processes with nodular pattern].
    Chirife AM; Bilbao ER; Giménez L; Marino L
    Medicina (B Aires); 2006; 66(4):307-12. PubMed ID: 16977965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia.
    Mazur G; Haloń A; Wróbel T; Urbaniak J; Kuliczkowski K; Woźniak M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():76-8. PubMed ID: 15638381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.